India's Stelis Biopharma to supply 200 mn doses of Sputnik V vaccine

Suptnik V. Credit: Reuters Photo

Indian drugmaker Strides Pharma Science said on Friday its unit Stelis Biopharma has partnered with the Russian Direct Investment Fund to produce and supply at least 200 million doses of the Sputnik V Covid-19 vaccine.